Wells Fargo Maintains Equal-Weight Rating on Amrize, Cuts Target to $39
Wells Fargo cut its price target to $39 per share from $40 while maintaining its Equal-Weight rating on Amrize.
Wells Fargo cut its price target to $39 per share from $40 while maintaining its Equal-Weight rating on Amrize.